How Much Did Sylke Raise?
Funding & Key Investors

Sylke has successfully secured a significant capital injection, marking a pivotal moment in its corporate trajectory. With a total funding accumulation of $5.5M, the firm is well-positioned to accelerate its market penetration. The most recent financing round, totaling $5.5M, underscores the confidence institutional backers have in the company's proprietary silk fibroin technology and its potential to disrupt the traditional wound closure market.

What is Sylke?

Sylke
ManufacturingMedical Devices & Equipment

Sylke operates at the intersection of advanced materials science and clinical medicine. By leveraging the unique biocompatibility of silk fibroin, the company has developed the SYLKE Adhesive Wound Closure, a product designed to replace conventional sutures and staples. This innovation addresses critical pain points in surgical and emergency care, specifically offering water resistance and immediate application capabilities. As a specialized medical device manufacturer, Sylke serves a diverse portfolio of healthcare systems and surgical centers, positioning itself as a high-growth entity within the global wound care sector. The company's commitment to clinical efficacy and user-centric design has established it as a formidable competitor against legacy medical supply incumbents.

How much funding has Sylke raised?

Sylke has raised a total of $5.5M across 1 funding round:

2024

Angel/Seed

$5.5M

Angel/Seed (2024): $5.5M, investors not publicly disclosed

Key Investors in Sylke

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Sylke?

With this major strategic investment, Sylke is poised to transition from a specialized innovator to a broader enterprise-level player. The capital will likely be deployed toward scaling manufacturing capabilities to meet rising demand from global healthcare systems and expanding clinical research to validate the long-term outcomes of silk-based closure solutions. Furthermore, the company is expected to leverage these resources to strengthen its intellectual property portfolio and enhance its distribution network. As Sylke continues to refine its product pipeline, the focus will remain on achieving widespread adoption among medical professionals, ultimately aiming to set a new standard for biocompatible skin closure technology in both elective and trauma-based surgical environments.

See full Sylke company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Food & BeverageManufacturing
Building MaterialsManufacturingFreight & Logistics ServicesTransportationTrucking, Moving & Storage
Automotive PartsManufacturing
ManufacturingPlastic, Packaging & Containers

Frequently Asked Questions Regarding Sylke Financial Insights

What are the most recent funding rounds that Sylke has completed, and what were the funding rounds?
Sylke has recently completed 1 funding rounds: Angel/Seed on Sep 25, 2024.
What is the total amount of funding Sylke has raised to date?
Sylke has raised a total of $5.5M in funding to date.
How many funding rounds has Sylke completed?
Sylke has completed 1 funding rounds.
How much funding did Sylke raise in its most recent funding round?
Sylke raised $5.5M in its most recent funding round.
Which was the largest funding round in Sylke's history?
The largest funding round in Sylke's history was $5.5M.
See more information about Sylke